APA (7th ed.) Citation

Kocheise, L., Piseddu, I., Vonderlin, J., Tjwa, E. T., Buescher, G., Meunier, L., . . . Schulze, K. (2024). Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease. Frontiers in immunology, 15, . https://doi.org/10.3389/fimmu.2024.1369747

Chicago Style (17th ed.) Citation

Kocheise, Lorenz, et al. "Corrigendum: PD-1/PD-L1 Immune Checkpoint Therapy Demonstrates Favorable Safety Profile in Patients with Autoimmune and Cholestatic Liver Disease." Frontiers in Immunology 15 (2024). https://doi.org/10.3389/fimmu.2024.1369747.

MLA (9th ed.) Citation

Kocheise, Lorenz, et al. "Corrigendum: PD-1/PD-L1 Immune Checkpoint Therapy Demonstrates Favorable Safety Profile in Patients with Autoimmune and Cholestatic Liver Disease." Frontiers in Immunology, vol. 15, 2024, https://doi.org/10.3389/fimmu.2024.1369747.